Advanced Communications, Networks, and Scientific Data Systems
ID: 1Type: Phase I
Overview

Topic

Advanced Communications, Networks, and Scientific Data Systems

Agency

Department of CommerceNational Institute of Standards and Technology

Program

Type: SBIRPhase: Phase IYear: 2024

Topic Link

https://www.sbir.gov/node/2474007

Additional Information

https://www.nist.gov/tpo/small-business-innovation-research-program-sbir
Timeline
  1. 1
    Release Oct 24, 2023 12:00 AM
  2. 2
    Open Oct 24, 2023 12:00 AM
  3. 3
    Next Submission Due Dec 22, 2023 12:00 AM
  4. 4
    Close Dec 22, 2023 12:00 AM
Description

The Department of Commerce's National Institute of Standards and Technology (NIST) is seeking proposals for the NIST FY 2024 Small Business Innovation Research (SBIR) Phase I program. The specific topic of the solicitation is "Advanced Communications, Networks, and Scientific Data Systems".

This solicitation aims to support research and development projects that focus on advancing communications, networks, and scientific data systems. The technology or research should have potential applications in various fields and industries, with a focus on improving communication systems, network infrastructure, and data management.

The Phase I program provides funding for feasibility studies and proof-of-concept research. The project duration is typically six months, and successful Phase I awardees may be eligible for Phase II funding.

Interested applicants should visit the NIST SBIR program website for more information and to access the solicitation documents. The application due date for this solicitation is December 22, 2023.

Files
No associated files provided.
Similar Opportunities
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required). This solicitation aims to support Small Business Concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require Federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) topic. This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).
DOD SBIR 24.4 Annual - Non-RF Transceiver Alternative Communicator (NRF-TAC)  
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the Non-RF Transceiver Alternative Communicator (NRF-TAC) through its SBIR program. The U.S. Army is interested in developing a small, energy-efficient transceiver that can wirelessly communicate between two points without using traditional radio frequency (RF) transport. The NRF-TAC device should be capable of transmitting and receiving signals up to 300 meters using non-standard means such as magnetic, acoustic, or infrared communication. The goal is to create a communication method that is difficult to detect and report in covert activities, enabling new mission deployment possibilities for remote sensor operation and control. The NRF-TAC should be self-contained, easily concealable, field programmable, and able to operate for at least 800 hours without intervention. The SBIR effort involves designing and building an innovative NRF-TAC prototype for realistic field application. Phase I involves creating a design with a documented rationale, while Phase II focuses on developing and testing a prototype. The potential applications of NRF sensor technology include home security, automotive crash sensing, additive manufacturing, and IoT. The solicitation is open until March 31, 2025. For more information, visit the [solicitation link](https://www.sbir.gov/node/2496865).